Evidence map›Paper›PMID 27623511›Full record

ArticleNuclear medicine communications2016

Pharmacokinetics and microbiodistribution of 64Cu-labeled collagen-binding peptides in chronic myocardial infarction.

Heejung Kim, Sung-Jin Lee, Jin Su Kim, Cynthia Davies-Venn, Hong-Jun Cho, Samuel J Won, Eden Dejene, Zhengsheng Yao, Insook Kim, Chang H Paik and 1 more

Abstract read
In one paragraph

Article in Nuclear medicine communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecular Imaging of the Heart.Comprehensive Physiology · 2019
    Review
  4. Emerging imaging targets for infiltrative cardiomyopathy: Inflammation and fibrosis.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2019
    Review
  5. Imaging the Cardiac Extracellular Matrix.Advances in experimental medicine and biology · 2018
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Heejung KimaRadiopharmaceutical Laboratory, Department of Radiology and Imaging Sciences, Clinical Center, Nuclear Medicine Division, National Institutes of Health, Bethesda bApplied and Developmental Research Directorate, Leidos Biomedical Research Inc., Frederick National Laboratory, Frederick, Maryland, USA cMolecular Imaging Research Center, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Sung-Jin Lee
Jin Su Kim
Cynthia Davies-Venn
Hong-Jun Cho
Samuel J Won
Eden Dejene
Zhengsheng Yao
Insook Kim
Chang H Paik
David A Bluemke
Leidos (United States) · USNational Institutes of Health · USKorea Institute of Radiological and Medical Sciences · KR

Funding

Molecular Biomedical Imaging Laboratory (NIBIB)ZIAEB000072 · NIBIB · NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING · PI BLUEMKE, DAVID · 2010 to 2017
$5.0M
Chemical Modifications Of Antibodies For Molecular TargetingZIACL002001 · CLC · CLINICAL CENTER · PI PAIK, CHANG HUM · 2009 to 2017
$0k
Molecular Biomedical Imaging Laboratory (CC)ZIACL090019 · CLC · CLINICAL CENTER · PI JONES, ELIZABETH C. · 2010 to 2017
$0k
CCR NIH HHS HHSN261200800001CIntramural NIH HHS ZIA CL090019NCI NIH HHS HHSN261200800001E
6 · The paper itself

Abstract

objectivesThe aim of the study is to evaluate the pharmacokinetics and microbiodistribution of Cu-labeled collagen-binding peptides.

methodsThe affinity constant (KD), association (ka), and dissociation rate constant (kd) for the peptide collagelin or its analog (named CRPA) binding to collagen were measured by biolayer interferometric analysis. Rats (n=4-5) with myocardial infarction or normal were injected intravenously with the Cu-labeled peptides or Cu-DOTA as a control. Dynamic PET imaging was performed for 60 min at 7-8 weeks after infarct. Fluorine-18 fluorodeoxyglucose PET imaging was performed to identify the viable myocardium. To validate the PET images, slices of heart samples from the base to the apex were analyzed using autoradiography and histology.

resultThe peptides bound to collagen with a KD of ∼0.9 µmol/l. The Cu-peptides and Cu-DOTA accumulated in the infarct area (confirmed by autoradiography and histology images) within 1 min of injection and were excreted rapidly through the renal system. The blood clearance curves were biphasic with elimination half-lives of 21.9±2.4, 26.2±4.6, and 21.2±2.1 min for Cu-CRPA, Cu-collagelin, and the control Cu-DOTA, respectively. The clearance half-lives from the focal fibrotic tissue (24.1±1.5, 25.6±8.0, and 21.4±1.3 min, respectively) and remote myocardium (20.8±0.7, 21.0±5.5, and 19.1±2.4 min, respectively) were not significantly different. The uptake ratios of infarct-to-remote myocardium (1.93±0.18, 2.15±0.38, and 1.88±0.08, respectively) for Cu-CRPA, Cu-collagelin, and Cu-DOTA remained stable for the time period between 10 and 60 min.

conclusionThe distribution of the Cu-collagelin probes corresponds to the heterogeneous distribution of expanded extracellular space in the setting of myocardial infarction. The overall washout rate from the fibrous tissue was determined by the slow washout rate (t1/2≥20 min) of the peptides from the extracellular space to the vasculature, not by the dissociation rate (t1/2<2 min) of the Cu-peptides from collagen.

Indexed as

AnimalsAutoradiographyChronic DiseaseCollagenCopper RadioisotopesDisease Models, AnimalHeartMyocardial InfarctionMyocardiumPeptidesPositron-Emission TomographyRadiopharmaceuticalsRatsTissue DistributionCollagenCopper RadioisotopesPeptidesRadiopharmaceuticals

Identifiers

PMID27623511
PMCPMC5077647
OpenAlexW2517629704

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.